All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 4, 2023
Home » Topics » Analysis and data insight

Analysis and data insight
Analysis and data insight RSS Feed RSS

Money raised by biopharma: 2019 vs. 2018

Dec. 6, 2019
No Comments
Total raised in public, private and other financings of biopharma companies, comparing 2019 vs. 2018.
Read More

Biopharmaceutical grants: October 2019

Dec. 6, 2019
No Comments
Grants received by biopharma companies in October 2019.
Read More
A look back at the stories covered this week

Biopharma equities push higher once again in November

Dec. 6, 2019
No Comments
A quick look back at top stories.
Read More

Biopharmaceutical grants: November 2019

Dec. 6, 2019
No Comments
Grants received by biopharma companies in November 2019.
Read More

Milestone payments from corporate partners in November 2019

Dec. 6, 2019
No Comments
Triggered milestone payments disclosed by biopharma companies in November 2019.
Read More

Venture capital and other private biopharma financings in November 2019

Dec. 6, 2019
No Comments
Venture capital and other private financings of private biopharma companies in November 2019.
Read More

Follow-on offerings of biopharma companies in November 2019

Dec. 6, 2019
No Comments
Follow-ons completed by biopharma companies in November 2019.
Read More

Other financings of public biotechnology companies in November 2019

Dec. 6, 2019
No Comments
Private placements and other private financings of public biopharma companies in November 2019.
Read More

Completed and pending biopharma IPOs in November 2019

Dec. 6, 2019
No Comments
Completed and pending initial public offerings by biopharma companies in November 2019.
Read More

Biopharma companies continue their strong momentum in November

Dec. 3, 2019
By Peter Winter
No Comments
After being in the doldrums for the majority of the year, public biopharmaceutical companies, it appears, have turned the corner and are now on a major upswing.
Read More
Previous 1 2 … 147 148 149 150 151 152 153 154 155 … 163 164 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 2, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 2, 2023.
  • Medical cannabis in blister pack of capsules

    Zelira’s stock triples as cannabinoid outperforms Lyrica in pain

    BioWorld
    Medicinal cannabis company Zelira Therapeutics Ltd.’s stock shot up 224% on May 31 on the heels of news that its cannabinoid product, ZLT-L-007, outperformed...
  • Cerebellum, brain stem, spinal cord

    Reprocell reports mixed results for phase II Stemchymal trial in spinocerebellar ataxia

    BioWorld
    Regenerative medicine product Stemchymal, an allogeneic adipose-derived mesenchymal stem cell treatment, missed the primary efficacy endpoints in two phase II...
  • EU flag, pills, syringe

    Otsuka’s schizophrenia drug filing U-turn amongst latest CHMP announcements

    BioWorld
    Otsuka Pharmaceutical Co. Ltd. has gone back on efforts to get its medicine, Asimtufii (aripiprazole), a long-acting maintenance treatment for schizophrenia,...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing